Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model

Epigenetic therapy for solid tumors could benefit from an in vivo model that defines tumor characteristics of responsiveness and resistance to facilitate patient selection. Here we report that combining the histone deacetylase inhibitor entinostat with the demethylating agent vidaza profoundly affec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Belinsky, Steven A., Grimes, Marcie J., Picchi, Maria A., Mitchell, Hugh D., Stidley, Chris A, Tesfaigzi, Yohannes, Channell, Meghan M., Liu, Yanbin, Casero, Robert A., Baylin, Stephen B., Reed, Mathew D., Tellez, Carmen S., March, Thomas H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3075424/
https://ncbi.nlm.nih.gov/pubmed/21224363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-3184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados